CAS No.668270-12-0 Linagliptin Pharmaceutical Intermediates
02
introduce
Linagliptin is an oral hypoglycemic agent used to treat type 2 diabetes.
It belongs to the DPP-4 inhibitor class of drugs and works by increasing incretin levels, thereby enhancing insulin secretion and lowering glucagon levels, ultimately achieving better blood sugar control.
As a leading manufacturer and trader, our company focuses on producing high-quality linagliptin that meets the stringent requirements of the pharmaceutical industry.
It belongs to the DPP-4 inhibitor class of drugs and works by increasing incretin levels, thereby enhancing insulin secretion and lowering glucagon levels, ultimately achieving better blood sugar control.
As a leading manufacturer and trader, our company focuses on producing high-quality linagliptin that meets the stringent requirements of the pharmaceutical industry.
02
Physical and chemical properties
Linagliptin possesses unique physical and chemical properties that make it effective in a variety of applications:
- Molecular Formula: C25H28N8O2
- Molecular weight: 472.54 g/mol
- Appearance: White powder
- Solubility: Soluble in dimethyl sulfoxide (DMSO), slightly soluble in water, making it easy to add to various formulations.
- Melting point: Approximately 200-205 °C (392-401 °F), indicating its thermal stability.
- pH value: Usually neutral, therefore suitable for a variety of drug applications.
These properties make linagliptin an ideal ingredient in pharmaceutical formulations, ensuring that the active ingredient can be delivered effectively and safely.
1. Effective blood sugar control: Linagliptin effectively lowers blood sugar levels by enhancing insulin secretion and reducing glucagon levels, making it an effective treatment option for type 2 diabetes.
2. Convenient administration method: Linagliptin's once-daily dosing regimen improves patient adherence and simplifies diabetes management.
3. Low risk of hypoglycemia: Unlike some other diabetes medications, linagliptin has a very low risk of causing hypoglycemia, making it a safer option for patients.
4. Normal weight: Linagliptin usually does not cause weight gain, which is an important consideration for many people with type 2 diabetes.
5. Affordable: Our integrated production and trading model enables us to offer competitive prices without sacrificing quality, making linagliptin an economical choice for pharmaceutical companies.
6. Customized Solutions: We understand that every client's needs are different. Our experienced team is dedicated to providing customized solutions to ensure that our linagliptin meets your specific requirements.
Linagliptin has a variety of applications in the pharmaceutical field:
- Diabetes Management: Primarily used to treat type 2 diabetes, it can be used alone or in combination with other antidiabetic medications.
- Combination therapy: Linagliptin can be used in combination with metformin or other diabetes medications to achieve better blood sugar control.
- Research and Development: Linagliptin's unique mechanism of action makes it a subject of ongoing research in other potential application areas of metabolic disorders.
In summary, linagliptin is a
highly effective and versatile treatment for type 2 diabetes.
With its superior
physicochemical properties and our unwavering commitment to quality and
customer satisfaction, we are your trusted linagliptin partner.
Whether you
require high-purity raw materials for diabetes formulations or other
therapeutic applications, our products are designed to meet the highest
performance and safety standards.
Contact us today to learn how our linagliptin
can support your pharmaceutical development and enrich your product pipeline.